Skip to main content

Serum_indogulf

HEXASIIL®

HEXASIIL®

HEXASIIL®

Ready to use Hexavalent Vaccine for active immunization of infants against Diphtheria, Tetanus, Pertussis, Hepatitis B, Poliomyelitis and invasive diseases caused by Haemophilus influenzae type b.

Ready to use Hexavalent Vaccine

Diphtheria, Tetanus, Pertussis (Whole Cell), Hepatitis B (rDNA), Poliomyelitis (Inactivated) and Haemophilus influenzae Type b Conjugate Vaccine (Adsorbed).

Therapeutic Indications

HEXASIIL® is indicated for active immunization of infants, at or above the age of 6 weeks against Diphtheria, Tetanus, Pertussis, Hepatitis B, Poliomyelitis and invasive diseases caused by Haemophilus influenzae type b for 3 dose regimen (6, 10 & 14 Weeks) for primary vaccination and booster dose at the age of 12-24 months.

Primary Vaccination

For active immunization of infants, it is recommended that 3 doses of 0.5 ml to be administered with an interval of at least four weeks between doses starting at six weeks of age.

In countries, where peri-natal transmission of hepatitis B virus (HBV) is common, the first dose of Hepatitis B should be given as soon as possible after birth. In this case, the HEXASIIL® can be used to complete the primary series from 6 weeks of age.

Booster Vaccination

A booster dose of DTP, Hib and IPV should be given preferably during the second year of life (≥ 6 months after last primary dose). Booster doses should be given in accordance with the official recommendations.

Method of Administration

The HEXASIIL® liquid vaccine vial/PFS should be shaken before use to homogenize the suspension. HEXASIIL® should be administered intramuscularly. The recommended injection sites are generally the antero-lateral aspect of the upper thigh in infants and toddlers. Do not administer by intravascular, intradermal or subcutaneous injection.

Pharmaceutical Form / Presentation

Single dose presentation: 1 dose vial of 0.5 ml.

Multi-dose presentation: 10 dose vial of 5 ml.

HEXASIIL® is a pinkish to yellowish turbid liquid in which the Aluminium Phosphate adjuvant tends to settle down slowly on storage.

Shelf-life
Unopened vial: shelf-life is 24 months.

Opened multidose vial: After first opening, the vaccine can be used for up to 28 days, provided it is stored between +2ºC to +8ºC.

Storage

Store in a refrigerator (+2ºC to +8ºC). Do not freeze. Discard vaccine if frozen. Keep the vaccine in the outer carton in order to protect from light.